NDUFA2: A Promising Drug Target for Nucleotide-Driven Unstructured Features

Target Name: NDUFA2

NCBI ID: G4695

NDUFA2

NDUFA2: A Promising Drug Target for Nucleotide-Driven Unstructured Features

National DNA User Forum (NDUFA) is a non-profit organization that focuses on advancing the science and application of DNA user facilities. It is a community-based organization that aims to improve the capabilities of DNA user facilities, and to promote the responsible use of DNA data.

NDUFA has been at the forefront of the efforts to understand the potential drug targets in the human genome. One of its key areas of focus is on the identification and characterization of potential drug targets, with a particular emphasis on the non-coding regions of the genome.

One of the organization's most promising areas of research is the study of the potential drug targets known as Nucleotide-Driven Unstructured Features-2 (NDUFA2) in the human genome. NDUFA2 is a non-coding RNA molecule that is expressed in a variety of tissues and cells, and it has been shown to play a key role in the regulation of gene expression.

Recent studies have suggested that NDUFA2 may be a promising drug target for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This is because NDUFA2 has been shown to be involved in the regulation of a wide range of cellular processes, including cell growth, differentiation, and inflammation.

One of the key reasons why NDUFA2 is considered a promising drug target is its location on the human genome. Unlike many other potential drug targets, NDUFA2 is located in the non-coding regions of the genome, which are often overlooked as potential drug targets. However, studies have shown that these regions of the genome can be just as important as the coding regions for drug development.

Another reason why NDUFA2 is considered a promising drug target is its biology. NDUFA2 has been shown to play a key role in the regulation of gene expression, and it is involved in the control of a wide range of cellular processes. This makes it an attractive target for drugs that aim to modify gene expression or cell behavior.

In addition, NDUFA2 has been shown to be involved in the regulation of cellular signaling pathways. This is another potential drug target that is of interest to researchers, as many diseases are caused by disruptions in cellular signaling pathways.

Overall, NDUFA2 is a promising drug target due to its location on the human genome, its biology, and its involvement in cellular signaling pathways. Further research is needed to fully understand the potential of NDUFA2 as a drug target, and to develop safe and effective treatments.

Protein Name: NADH:ubiquinone Oxidoreductase Subunit A2

Functions: Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone

The "NDUFA2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NDUFA2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets